Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Zymeworks Inc.

NASDAQ: ZYME · Life Sciences · 7 alerts · CIK 1937653

Share price
$26.45Close, Nov 16
Market cap
$1.83B
Shares outstanding
69.03MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Zymeworks Inc. filings on SEC EDGAR ↗

6:07 AM ET 8-K
Licensing Deal

Zymeworks Licensing Deal with Roche Worth $813M

Zymeworks entered into a global collaboration and license agreement with Roche for the development and commercialization of ZW209, a trispecific T-cell engager targeting DLL3. Zymeworks will receive a $55 million upfront payment and a $40 million milestone upon Phase 1b trial initiation, with eligibility for up to $718 million in additional milestones plus tiered royalties.

Value
$813M
Counterparty
Roche

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.